2/21/2025India Can Surpass China in Drug Discovery, Says Biocon Chief

2/21/2025Novo Nordisk Sues KBP Biosciences for $830 Million Over Alleged Fraud

2/21/2025NMPA Announces Package Insert Revision of Fluorouracil Injection

2/21/2025MediLink's YL217 Received FDA Clearance of IND Application

2/21/2025Hengrui Medicine Advances Dual GLP-1/GIP Agonist HRS9531 with First Ph...

2/21/2025Recent Executive Moves

2/21/2025Lessons from China's 2024 National Negotiation of Drug Prices (GT)

2/20/2025Ascletis Reports Positive Interim Results from U.S. Phase Ib Study of ...

2/20/2025Chimigen Secures CNY100M+ in Pre-A Financing to Advance Cancer and Hep...

2/19/2025CSPC Pharma Partners with Radiance for Global Development of Anticance...

2/19/2025Pharma Industry Faces Uncertainty Amid Potential U.S. Tariffs on Chin...

2/19/2025Genuine Biotech Submits Second IPO Application amid Hong Kong Market R...

2/19/2025China Holds 2025 National Drug Regulation Conference, Setting Key Prio...

2/19/2025It's Not Just AI. China's Medicines Are Surprising the World, Too (Eco...

2/18/2025How China and Indian Biotech are Teaming Up to Conquer the Global Mark...

2/18/2025The Drug Industry Is Having Its Own DeepSeek Moment (WSJ)

2/18/2025Cash-Strapped Chinese Biotechs A Growing Draw For Western Pharma Partn...

2/18/2025China Performance of Leading MNCs Fell in H2/2024: A Turning Point?

2/18/2025QL Biopharma Secures ¥100M Series C Financing to Advance Treatments f...

2/18/2025Zydus Partners with Beihai to Launch BEIZRAY in the U.S.

2/18/2025Polymed Licenses IRAK4-Targeting Protein Degrader HPB-143 to Photys

2/18/2025META Pharmaceuticals Completes Series A1 Financing Led by XtalPi

2/18/2025Huadong Medicine Announces Positive Results from HDM1005 Clinical Tria...

2/18/2025BioKin Initiates Phase III Trial in China for BL-B01D1 in NSCLC

2/18/2025NovoCodex's ARX788 Demonstrates Efficacy in HER2-Positive Advanced Bre...

2/18/2025WuXi XDC in Strategic Transformation through Ownership Shift and Capit...

2/17/2025CSPC's SYS6005 ADC Enters Phase I Clinical Trials in China

2/17/2025BioNTech Initiates Phase 1/2 Trial for BNT327 and BNT323 Combination i...

2/17/2025Betta Pharma's Xcovery Initiates EMA Approval Process for Ensartinib i...

2/17/2025Aurobindo Pharma to Begin European Supplies from China Facility in Apr...

Page:12/764 Total number of articles:22895: [First][<<] [10] [11] [12] [13] [14] [>>] [End]